secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Health Inc. (—)
CIK:        0001628945
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001193125-24-072864
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Health CEO Ayub Khattak steps down; co-founder Clint Sever appointed CEO
----------------------------------------------------------------------------

- Ayub Khattak resigned as CEO, President, and Chairman effective March 19, 2024; remains on board.
- Co-founder Clint Sever, previously Chief Product Officer, appointed CEO effective March 20, 2024.
- Board appointed Dr. Paul Brown (ex-Roche Molecular) and Dr. Lisa Danzig (ex-Grifols) as strategic advisors.
- Company will initiate comprehensive business and operational review to refine strategy and reduce costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628945/000119312524072864/0001193125-24-072864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628945/000119312524072864/d789392d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-072864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer